Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Flexion Therapeutics, Inc. (FLXN)

« Back to company index

FLXN Chatter Timeline

Stock Ticker for FLXN

Most Active Tweeters for FLXN

UserTweets
@Tickeron 7
@kursadbucak 6
@AmericanBanking 3
@TheMarketsDaily 3
@macondailynews 3

Recent Tweets for FLXN

SheffStation @SheffStation
$FLXN..$14.55..sNDA for new labeling is Oct 14th. Product already on the market. One on watch! Seems like a low hur… https://t.co/DQ1hR6OdAv
1:09pm
dakotafinancial @dakotafinancial
Zacks: Analysts Expect Flexion Therapeutics Inc $FLXN Will Announce Earnings of -$1.01 Per Share https://t.co/uB5LkBOYbC
September 15th 2019, 8:09pm
macondailynews @macondailynews
$18.85 Million in Sales Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/UC9rEUj9BH
September 15th 2019, 1:09pm
TheMarketsDaily @TheMarketsDaily
$18.85 Million in Sales Expected for Flexion Therapeutics Inc $FLXN This Quarter https://t.co/ijtGgPeKhW
September 15th 2019, 1:09pm
Gambiste1 @Gambiste1
RT @biotechw2019: $FLXN kissed the weekly cloud. Not too easy to break inside the cloud. May need some news to break the cloud ! https://t.…
September 14th 2019, 9:09pm
biotechw2019 @biotechw2019
$FLXN kissed the weekly cloud. Not too easy to break inside the cloud. May need some news to break the cloud ! https://t.co/zk80ZnQXw8
September 14th 2019, 8:09pm
macondailynews @macondailynews
Flexion Therapeutics $FLXN PT Set at $20.00 by Northland Securities https://t.co/3uB2gzf67C
September 14th 2019, 7:09pm
TheMarketsDaily @TheMarketsDaily
Flexion Therapeutics $FLXN PT Set at $20.00 by Northland Securities https://t.co/007JAJLnIV
September 14th 2019, 7:09pm
dispatchtribune @dispatchtribune
Flexion Therapeutics $FLXN Raised to “Buy” at ValuEngine https://t.co/Z7f87daGqF
September 14th 2019, 1:09pm
OlympiaReport @OlympiaReport
Flexion Therapeutics $FLXN Upgraded by ValuEngine to “Buy” https://t.co/HRFofyIthq
September 14th 2019, 1:09pm
WeekHerald @WeekHerald
Flexion Therapeutics $FLXN Raised to “Buy” at ValuEngine https://t.co/8GBnlT7JOz
September 14th 2019, 1:09pm
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on August 24, 2018. View odds for this… https://t.co/jvCeENi3qd
September 14th 2019, 2:09am
ZolmaxNews @ZolmaxNews
Flexion Therapeutics $FLXN Given a $20.00 Price Target by Northland Securities Analysts https://t.co/A3FxEPtPRR
September 13th 2019, 9:09pm
TickerReport @TickerReport
Northland Securities Reiterates “$20.00” Price Target for Flexion Therapeutics $FLXN https://t.co/Bq8Rab15uq
September 13th 2019, 9:09pm
dailypoliticaln @dailypoliticaln
Northland Securities Reiterates “$20.00” Price Target for Flexion Therapeutics $FLXN https://t.co/diMwpBqb94
September 13th 2019, 9:09pm
TickerReport @TickerReport
Flexion Therapeutics $FLXN Stock Rating Upgraded by ValuEngine https://t.co/fNfMpJiZF3
September 13th 2019, 10:09am
Tickeron @Tickeron
$FLXN in Uptrend: RSI indicator stops in overbought zone for 1 day. View odds for this and other indicators:… https://t.co/4sb6bAervW
September 12th 2019, 11:09pm
ZolmaxNews @ZolmaxNews
Flexion Therapeutics $FLXN Upgraded to Buy by ValuEngine https://t.co/fCAYybuvnm
September 12th 2019, 9:09pm
AmericanBanking @AmericanBanking
Brokerages Expect Flexion Therapeutics Inc $FLXN Will Announce Quarterly Sales of $18.85 Million https://t.co/1antEfTiIv #stocks
September 12th 2019, 7:09am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on August 24, 2018. View odds for th… https://t.co/IC0XBfgVVb
September 12th 2019, 12:09am
stocknewstimes @stocknewstimes
Flexion Therapeutics $FLXN Upgraded at ValuEngine https://t.co/Rc2QnapuLJ
September 12th 2019, 12:09am
TranscriptDaily @TranscriptDaily
ValuEngine Upgrades Flexion Therapeutics $FLXN to “Buy” https://t.co/t8VrLgXCdC
September 12th 2019, 12:09am
TheMarketsDaily @TheMarketsDaily
ValuEngine Upgrades Flexion Therapeutics $FLXN to “Buy” https://t.co/omYydHsAHZ
September 12th 2019, 12:09am
TranscriptDaily @TranscriptDaily
Flexion Therapeutics $FLXN Given a $20.00 Price Target at Northland Securities https://t.co/XYbEaW4IFS
September 11th 2019, 10:09pm
stocknewstimes @stocknewstimes
Flexion Therapeutics $FLXN Given a $20.00 Price Target at Northland Securities https://t.co/BRGKterIqR
September 11th 2019, 10:09pm
dakotafinancial @dakotafinancial
Flexion Therapeutics $FLXN Given a $20.00 Price Target by Northland Securities Analysts https://t.co/lJ3LccDwL8
September 11th 2019, 9:09pm
AmericanBanking @AmericanBanking
Flexion Therapeutics $FLXN Given a $20.00 Price Target by Northland Securities Analysts https://t.co/JKP7l6Xo3S #stocks
September 11th 2019, 9:09pm
kursadbucak @kursadbucak
$1.87 to the price target.. $flxn #flxn @FlexionInc https://t.co/sD8yVubxIt https://t.co/aydN26sjLh
September 11th 2019, 7:09pm
kursadbucak @kursadbucak
Last $1.98 to the price target gate. $flxn #flxn @FlexionInc https://t.co/VoZeVGxStc https://t.co/bTOthnAycL
September 11th 2019, 2:09pm
Tickeron @Tickeron
$FLXN enters an Uptrend because Momentum Indicator exceeded the 0 level on August 28, 2019. View odds for this and… https://t.co/2QiyN2SDur
September 11th 2019, 12:09am
macondailynews @macondailynews
Flexion Therapeutics $FLXN Stock Price Up 7.1% https://t.co/9Fh9shK0Sq
September 10th 2019, 11:09pm
kursadbucak @kursadbucak
Last $2.25 to enter the price target gate $flxn #flxn @FlexionInc https://t.co/UoQb3qamPX
September 10th 2019, 5:09pm
SeekingAlpha @SeekingAlpha
$FLXN - Flexion Therapeutics: Zilretta's Uptake Improves https://t.co/DDy2APZ1uz
September 10th 2019, 4:09pm
kursadbucak @kursadbucak
Last $2.5 to the price target. $flxn #flxn @FlexionInc https://t.co/xF9ukeSAmc https://t.co/yz2MH74Ce9
September 10th 2019, 1:09pm
kursadbucak @kursadbucak
$2.73 left to the price target. $flxn #flxn @FlexionInc https://t.co/cocKXNDYOP https://t.co/CsFTiED5xQ
September 10th 2019, 11:09am
Gambiste1 @Gambiste1
RT @adam_muzikant: We are taking a unique approach at $FLXN to post-operative pain, enabled via our acquisition of a NaV1.7 inhibitor from…
September 10th 2019, 10:09am
adam_muzikant @adam_muzikant
We are taking a unique approach at $FLXN to post-operative pain, enabled via our acquisition of a NaV1.7 inhibitor… https://t.co/SoNrmVPS6X
September 10th 2019, 9:09am
AmericanBanking @AmericanBanking
Flexion Therapeutics Inc $FLXN Expected to Post Earnings of -$1.01 Per Share https://t.co/VQVi76sJBw #stocks
September 10th 2019, 6:09am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $FLXN is 1.62 out of 5. https://t.co/DGmMnBcnUj
September 10th 2019, 6:09am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average broke below 200-day Moving Average on August 24, 2018. View odds for this… https://t.co/VwdwMkEbSX
September 10th 2019, 12:09am
Briefingcom @Briefingcom
$FLXN: Flexion Therapeutics and Xenon Pharmaceuticals (XENE) announce agreement for XEN402 development rights https://t.co/zQHN6deJ4E
September 9th 2019, 6:09pm
MSollender @MSollender
$FLXN $XENE Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV… https://t.co/uWA0Dtk75x
September 9th 2019, 4:09pm
dailypoliticaln @dailypoliticaln
Flexion Therapeutics Inc $FLXN Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/cpWvwDAXIL
September 9th 2019, 4:09pm
WatchlistN @WatchlistN
Flexion Therapeutics Inc $FLXN Receives $23.17 Consensus Target Price from Brokerages https://t.co/oHVSsiSAXl
September 9th 2019, 3:09pm
kursadbucak @kursadbucak
$2.96 left to the price target $flxn #flxn @FlexionInc https://t.co/EsRdqQ1lfr https://t.co/nXVWNDnp9P
September 9th 2019, 11:09am
CentralChartsEN @CentralChartsEN
$FLXN #FLEXIONTHERAPEUTICS - Daily: The bullish trend is currently very strong on FLEXION THERAPEUTICS INC.. As lon… https://t.co/WOKIfaOuSE
September 9th 2019, 4:09am
Londinia_IA @Londinia_IA
$FLXN #FLEXIONTHERAPEUTICS - Daily: The bullish trend is currently very strong on FLEXION THERAPEUTICS INC.. As lon… https://t.co/V8IHX7x6Fj
September 9th 2019, 4:09am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on August 24, 2018. View odds for this… https://t.co/BwfxFUgp0d
September 8th 2019, 11:09pm
bbnsnews @bbnsnews
Flexion Therapeutics $FLXN Rating Increased to Buy at BidaskClub https://t.co/c9SFvintME
September 8th 2019, 10:09am
Tickeron @Tickeron
$FLXN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on August 24, 2018. View odds for th… https://t.co/IKHhxJZkDT
September 8th 2019, 12:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.